| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |